[Therapeutic use of piracetam in myocardial infarct patients].
Fifty-four patients with acute myocardial infarction were evaluated repeatedly, with 28 of those treated with piracetam, and 26 used as controls. Piracetam produced a considerable favorable effect on the clinical course of myocardial infarction, as reflected in a more rapid clinical improvement of acute circulatory insufficiency and an analgetic effect. The drug reduced heart rate and moderately elevated systolic arterial blood pressure. Positive changes in total CPK, LDH, AST and ALT activities, and in ECG from 12 and 35 leads were quicker to come.
D000208:Acute Disease; D000700:Analgesics; D000787:Angina Pectoris / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D004796:Clinical Enzyme Tests; D003326:Coronary Circulation; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010889:Piracetam / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*
D000700:Analgesics; D011760:Pyrrolidinones; D010889:Piracetam
Lechebnoe primenenie piratsetama u bol'nykh infarktom miokarda.